Posted on 02/07/2006 10:13:40 AM PST by Calpernia
How do you say No NAIS in Japanese?
The USDA and the agricultural business giants have been crafting a national animal identification scheme that threatens the freedoms of the citizens of the United States of America. The National Animal Identification System (NAIS) is the creation of various businesses, such as Monsanto Company, to monopolize American food production by using fear tactics to advance their agenda. The NAIS scheme was not created by any act of our government. NAIS is merely a presumptuous bureaucratic dictate.
So who is Monanto Company?
In the late 1970s, Monsanto developed a longer-term strategy that would enable it to reduce its dependence on low-return petroleum-based products. A central feature of the strategy involved an increase in activity in the areas of nutritional chemicals and agricultural products and a move into the new area of health care. Biotechnology, particularly genetic engineering, was attractive since it affected all three of these areas. In 1979 Monsanto hired Dr. Howard A. Schneiderman, a biochemist from the University of California, Irvine, who became a senior Vice-President and Chief Scientist in charge of the Corporate Research and Development Division. It was Schneiderman who spearheaded the company's drive into biotechnology and genetic engineering. To facilitate its move into new areas, the company's R&D budget was increased considerably, from 2.6% of sales in 1979 to 5% in 1983 and 7% in 1985 (Monsanto, 1985). In 1985, 57% of R&D expenditure was in the area of life sciences. With 1985 sales of $6,747 million, the R&D budget for 1986 is around $470 million, implying a research budget of about $270 million in the life sciences. Monsanto has followed a number of paths in its attempt to build its biotechnology-related capabilities. To begin with, Monsanto has established links with universities. Most important of these has been a link with the School of Medicine at Washington University in St. Louis. Monsanto provided the university with $23.5 million over five years in return for cooperative research projects in biotechnology. One benefit the company has received from this relationship is G.D. Searle & Co.'s development of atrial peptides, which control high blood pressure; these compounds were originally isolated and identified by Professor Philip Needleman, Head of the Pharmacology Department at the University. Monsanto has signed research agreements with a number of other universities, including Harvard, Oxford, and Rockefeller Universities. The company's university links were the subject of a congressional enquiry, headed by then Congressman Al Gore, which concluded that the relationship was not detrimental to the university system.
Intellectual Property and Research
The company's univeristy links also show an interesting intellectual property rights issue. Example, with the Monsanto-Washington University link is intended to facilitate cooperative work between company and university scientists working collaboratively on research projects. An eight-member advisory committee divided equally between Monsanto researchers and Washington University faculty makes the final decision regarding research funding. The agreement stipulates that 30% of the research will be basic research, while 70% will be research directly applicable to human disease. The United States Congress, Office of Technology Assessment Report on Biotechnology (1984) summarized the provisions regarding intellectual property rights: 'Washington University faculty members will be at liberty to publish results of any research done under the Monsanto funding. Monsanto will exercise the right of prior review of draft materials, because they may contain potentially patentable technical developments. If they do, Monsanto can request a delay of submission for publication or other public disclosure in order to begin the patent process'. Patent rights will be retained by Washington University but Monsanto will have exclusive rights to licences. If Monsanto chooses not to license a patent then the university will be free to issue the licence to others. Royalties will go to Washington University and not to the individual researchers, but will normally go to their laboratory.
The Database
Monsanto then gives the universities access to their vast corporate digital library initiatives. Monsanto's online solution was a pioneering effort that provides a vast knowledge sharing through the Internet that includes data and solutions for:
Monsanto and Biotechnology
Along with universities, Monsanto has been linking with biotechnology firms through acquisition and mergers, marketing agreements, contractual agreements to provide assets, and joint ventures.
One such company Monsanto has developed a relationship with is Mitsubishi Pharma Corp. Mitsubishi itself has an interesting corporate history. The smaller businesses that eventually merged into Mitsubishi Pharma Corporation are worth mentioning.
Green Cross Corporation was founded in 1950 as Japan's first commercial blood bank and became a diversified international pharmaceutical company producing ethical drugs for delivery or administration by doctors and healthcare workers. It included war criminals such as Kitano Masaji who performed human experimentation in Unit 731 of the Japanese military during World War II.
The company merged into Yoshitomi Pharmaceutical Co., Ltd On April 1, 1998, and renamed to Welfide Corporation on April 1, 2000. Finally Welfide Corp. and Mitsubishi-Tokyo Pharmaceutical Inc. were mereged to form Mitsubishi Pharma Corp. on October 1, 2001.
Throughout their history of company names, there follows a history of tainted blood scandals.
Japan's HIV-tainted blood scandal, known in Japanese as, yakugai eizu jiken, refers between one and two thousand cases in the 1980s in which Japanese patients with haemophilia contracted HIV via tainted blood products. The man that was found guilty of professional negligence resulting in these deaths, Matsushita Renzo, former head of the Ministry of Health and Welfare's Pharmaceutical Affairs Bureaum, became president of Green Cross and after serving his jail time.
Nanotechnology Micro-scale machines, such as DNA chips
The term "nanotechnology" was named in 1974 by Tokyo Science University professor Norio Taniguchi, author of "Nanotechnology: Integrated Processing Systems for Ultra-Precision and Ultra-Fine Products".
Genes and the products of genetic engineering can be patented and owned. In 1980, two federal landmark decisions influenced the business side of biotechnology. A Supreme Court ruling allowed patents to be granted for genetically engineered organisms, processes of transforming cells and expressing proteins, and genes themselves. More recently, the Federal Circuit Court of Appeals reversed a Patent Office decision and ruled that DNA sequences that code for particular proteins are patentable. The Bayh Dole Act rules that all intellectual property resulting from federal funding resides in the university, rather than in the government. Unless, the univeristy link is linked to funding by a company, such as Monsanto.
This is what is fueling the drive for a major restructuring of the agriculture, food, and fiber industries. The Bio and now Nanotechnology sciences have presented fundamental problems for the protection of intellectual property rights. As the main OECD publication on patent protection has put it (Beier et al., 1985):
"In the past the patent system rested safely on a semantically clear [and] objectively defensible separation between (patentable) invention' and (non-patentable) 'discovery'. The recent development of biotechnology where some scientific discoveries could be turned into commercial products almost immediately has blurred this separation. This may have far-reaching legal and practical consequences."
Monsanto has sued hundreds of farmers for saving gene-altered seeds from each year's harvest to replant their fields the following season -- a practice farmers have followed for years. In fact, three-quarters of the world's growers are subsistence farmers who rely on saved seed. Monsanto claims "seed piracy" and said replanting the company's patented, gene-altered seeds violates a three-year-old company rule requiring that farmers buy the seeds fresh every year. Monsanto does not sell its engineered seeds in the traditional sense but "leases" them, in effect, for one time use only.
The Creation of National Animal Identification System
Monsanto and other agricultural business giants have successfully laid the ground work to implement a "lease" on all of the United State's agriculture. The NAIS plan requires two types of mandatory registration for everyone who owns even just one animal. First, owners must register their name, home address, telephone number and Global Positioning System (GPS) coordinates of their 'premise' in a vast corporate digital library. Secondly, in order for any animal to leave its 'premise', the owner will be required to obtain an ID number for it which will be kept in a vast corporate digital library and have the animal microchipped.
The NAIS requirements have yet been forthright as to whether DNA samples will be required in the future.
ping
PING
BTTT
For FYI
http://animalid.aphis.usda.gov/nais/index.shtml
Don't get me started on the Equine Passport!!
arigato!
http://nationalpropertyowners.org/holt.ppt
Animal Passports - EQUINE INTERSTATE PASSPORT CONCEPT
No NAIS graphic made by freeper devolve.
Thank you!
Bar code by potlatch!
THANK YOU also!
ping
Not sure how NAIS is going to work out with that sort of livestock.
Maybe they will have them barcoded like the eggs?
????
Hey! I know some Beekeepers that you can refer those illegals too, since they have branding experience and are now out of work.
Sorry to hear about the loss of your livestock.
:)
;)
Cross your arms like an X, in front of you, and keep repeating...'No, NAIS...No, NAIS', eventually they will understand. Making a sucking sound with your teeth closed will help also.
Not complying with the microchipping is a Class C felony. You will lose your rights to bear arms and vote.
"Hey! I know some Beekeepers ..."
Would those be Freeperbeekeepers by any chance?
 |
 |
bump
If it is for agriculture only, it may have a chance in passing. If it is for all animals, including pets, there will be a huge public outcry. Maybe we should work on getting pets included so there will be a huge publicity backlash.
Matter of fact, trees are included.
http://www.cfr.washington.edu/research.pfc/presentations/rfid_seedlings/pages/slideA_gif.htm
More at link
I have been following this "Mark of the Beast" like program but do not have the time to put together a brief on it.
Once they have successfully tagged and numbered all the tens of millions of animals in the USA, they will point to NAIS' "success" and try to get us tagged and chipped as well.
BTTT
http://www.freerepublic.com/focus/f-news/1565481/posts
USDA steps up efforts to track livestock
http://nationalpropertyowners.org
National Property Owners
Full research sections on National Animal Identification System (NAIS)
http://www.freerepublic.com/focus/f-news/1563271/posts
Healthy People 2010
Information on where the funding came from for NAIS
http://www.freerepublic.com/focus/f-chat/1561077/posts
Animal Tagging and SCHOOL LUNCHES???
Information on some of the partners on these posts
http://www.freerepublic.com/focus/f-news/1564815/posts
Digital Angel and Microchip
Info on the technology that will be used for the tagging
Not complying with the microchipping is a Class C felony. You will lose your rights to bear arms and vote.
NAIS is troubling on a lot of levels, but frankly the tactic of demonizing corporations such as Monsanto as a way of derailing its implementation is a transparent leftist ploy which is as intellectually bankrupt and disingenuous as chanting the mantra of Halliburton, Halliburton, Halliburton as a way of criticizing the Iraq war.
seems something you'd find of interest
Looks like someone may be trying to short Monsanto stock.
No, I don't own Monsanto stock.
And I didn't suggest that you did. I suggested that you might be trying to short it. And you haven't denied that yet, have you?
How I can I short stock if I don't own any?
Easier than shorting stock when you do own it.
You basically borrow the shares, sell them, spread rumors about the company, watch the shares drop, buy the cheap shares to pay back the person from whom you borrowed the shares, and keep the profit.
iie. That's how you say it in Japanese (in Romaji)
I don't know how to borrow or buy stock.
I've never owned stock. I'm not interested in doing it either.
Sorry Par, can't help you here.
iie is no in Japanese?
Hai (which is yes in Japanese).
So you just trash Monsanto for the fun of it, without profiting from your actions?
Yes.
arigato.
Do itashi mashite (Twern't nothing ma'am)
'Twern't' translate???
;)
Thanks Calpernia but Google had the barcode and devolve worked with it, sized it and put the text on. It is his work.
Finding images for others is just a 'friendly Freeper' thing, lol!
Looks great devolve, Joe Cool approves!
Our children will find being chipped to be perfectly natural. After all, they have had a cell phone "implanted" on their hips almost since birth.
Wow. Thank you for all this information.
IG Farben (short for Interessen-Gemeinschaft Farbenindustrie AG) (and also called I.G. Farbenfabriken) was a German conglomerate of companies formed in 1925 and even earlier during World War I. Farben is German for "paints", "dyes", or "colors", and initially many of these companies produced dyes, but soon began to embrace more and more advanced chemistry. The founding of the IG Farben was a reaction to Germany's defeat in the First World War. IG Farben held a near total monopoly on the chemical production, later during the time of Nazi Germany. It is the German chemical firm that was the financial core of the Hitler regime, and was the main supplier of Zyklon-B to the German government during the extermination phase of the Holocaust. Before the war the dyestuff companies had a near monopoly in the world market which they lost during the conflict. One solution for regaining this position was a large merger.
IG Farben consisted of the following major companies and several smaller ones.
* AGFA
* Casella
* BASF (Badische Anilin und Soda Fabrik)
* Bayer
* Hoechst
* Huels
* Kalle
The I.G. Farben Building, headquarters for the conglomerate in Frankfurt/Main, Germany, was completed in 1931.
During the planning of the invasion of Czechoslovakia and Poland, IG Farben cooperated closely with the Nazi officials and directed which chemical plants should be secured and delivered to IG Farben.
In 1941, investigation exposed a "marriage" between Standard Oil Co. and I.G. Farben. It also brought new evidence concerning complex price and marketing agreements between duPont, a major investor in and producer of leaded gasoline, U.S. Industrial Alcohol Co. and their subsidiary, Cuba Distilling Co. The investigation was eventually dropped, like dozens of others in many different kinds of industries, due to the need to enlist industry support in the war effort. However, the top directors of many oil companies agreed to resign and oil industry stocks in molasses companies were sold off as part of a compromise worked out.
IG Farben built a factory for producing synthetic oil and rubber (from coal) in Auschwitz, which was the beginning of SS activity and camps in this location during the Holocaust. At its peak in 1944, this factory made use of 83,000 slave laborers. The pesticide Zyklon B, for which IG Farben held the patent and which was used in the gas chambers for mass murder, was manufactured by Degesch (Deutsche Gesellschaft für Schädlingsbekämpfung), a company owned equal 42.2 percent in shares by IG Farben and which had IG managers in its Managing Committee.
Of the 24 directors of IG Farben indicted in the so-called IG Farben Trial (1947-1948)c before a U.S. military tribunal at the subsequent Nuremberg Trials, 13 were sentenced to prison terms between 1½ and eight years.
Due to the severity of the war crimes committed by IG Farben during World War II and the extensive involvement of the management in the Nazi atrocities, the company was considered to be too corrupt to be allowed to continue to exist, and the allies considered confiscating all of its assets and putting it out of business. Instead, in 1951, the company was split up into the original constituent companies. The four largest quickly bought the smaller ones, and today only Agfa, BASF, and Bayer remain, while Hoechst merged with the French Rhône-Poulenc Rorer to form Aventis, now based in Strasbourg, France.
After the Holocaust, I.G. Farben joined with Americans to develop chemical warfare agents. Together they founded the "Chemagrow Corporation" in Kansas City, Missouri. The Chemagrow Corporation employed German and American specialists for the U.S. Army Chemical Corps. Dr. Otto Bayer was I.G. Farben's research director. He developed and tested chemical warfare agents with Dr. Gerhard Schrader.
In 1967, Monsanto entered into a joint venture with IG Farben.
Even though the company was officially liquidated in 1952, it continued to be traded on the Frankfurt Stock Exchange as a trust, holding a few real estate assets until it was finally declared bankrupt on November 10, 2003 by its liquidators, after contributing 500,000 Deutschmarks (160,000 British pounds or 233,000 American dollars) towards a foundation for former slave laborers under the Nazi regime and the remaining property, worth 21 million Deutschmarks (6.7 million British pounds or 10 million American dollars) going to a buyer. During this lengthy period, the holding company had been continually criticized for failing to pay any compensation to the slave laborers, which was the stated reason for its continued existence after 1952. The company, in turn, blamed the ongoing legal disputes with the former slave laborers as being the reason it could not be legally dissolved and the remaining assets distributed as reparations. Each year, the company's annual meeting in Frankfurt was the site of demonstrations by hundreds of protesters.
David W. Beier . . .former head of Government Affairs for Genentech, Inc., . . .now chief domestic policy advisor to Al Gore, Vice President of the United States.
Linda J. Fisher . . .former Assistant Administrator of the United States Environmental Protection Agency's Office of Pollution Prevention, Pesticides, and Toxic Substances, . . .now
Vice President of Government and Public Affairs for Monsanto Corporation.
Michael A. Friedman, M.D. . . former acting commissioner of the United States Food and Drug Administration (FDA) Department of Health and Human Services . . .now senior vice-president for clinical affairs at G. D. Searle & Co., a pharmaceutical division of Monsanto Corporation.
L. Val Giddings . . . former biotechnology regulator and (biosafety) negotiator at the United States Department of Agriculture (USDA/APHIS), . . .now Vice President for Food & Agriculture of the Biotechnology Industry Organization (BIO).
Marcia Hale . . . former assistant to the President of the United States and director for intergovernmental affairs, . .
.now Director of International Government Affairs for Monsanto Corporation.
Michael (Mickey) Kantor. . . former Secretary of the United States Department of Commerce and former Trade Representative of the United States, . . .now member of the board of directors of Monsanto Corporation.
Josh King . . . former director of production for White House events, . . . now director of global communication in the Washington, D.C. office of Monsanto Corporation.
Terry Medley . . . former administrator of the Animal and Plant Health Inspection Service (APHIS) of the United States Department of Agriculture, former chair and vice-chair of the United States Department of Agriculture Biotechnology Council, former member of the U.S. Food and Drug Administration (FDA) food advisory committee, . . . and now Director of Regulatory and External Affairs of Dupont Corporation's Agricultural Enterprise.
Margaret Miller . . . former chemical laboratory supervisor for Monsanto, . . .now Deputy Director of Human Food Safety and Consultative Services, New Animal Drug Evaluation Office, Center for Veterinary Medicine in the United States Food and Drug Administration (FDA).*
Michael Phillips . . . recently with the National Academy of Science Board on Agriculture . . . now head of regulatory affairs for the Biotechnology Industry Organization.
William D. Ruckelshaus . . . former chief administrator of the United States Environmental Protection Agency (USEPA), . . .now (and for the past 12 years) a member of the board of directors of Monsanto Corporation.
Michael Taylor . . . former legal advisor to the United States Food and Drug Administration (FDA)'s Bureau of Medical Devices and Bureau of Foods, later executive assistant to the Commissioner of the FDA, . . . still later a partner at the law firm of King & Spaulding where he supervised a nine-lawyer group whose clients included Monsanto Agricultural Company, .
. . still later Deputy Commissioner for Policy at the United States Food and Drug Administration, . . . and later with the law firm of King & Spaulding. . . . now head of the Washington, D.C. office of Monsanto Corporation.*
Lidia Watrud . . . former microbial biotechnology researcher at Monsanto Corporation in St. Louis, Missouri, . . .now with the United States Environmental Protection Agency Environmental Effects Laboratory, Western Ecology Division.
Jack Watson. . .former chief of staff to the President of the United States, Jimmy Carter, . . .now a staff lawyer with Monsanto Corporation in Washington, D.C.
Clayton K. Yeutter . . . former Secretary of the U.S. Department of Agriculture, former U.S. Trade Representative (who led the U.S. team in negotiating the U.S. Canada Free Trade Agreement and helped launch the Uruguay Round of the GATT negotiations), now a member of the board of directors of Mycogen Corporation, whose majority owner is Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company.
Larry Zeph . . . former biologist in the Office of Prevention, Pesticides, and Toxic Substances, U.S. Environmental Protection Agency, . . . now Regulatory Science Manager at Pioneer Hi-Bred International.
*Margaret Miller, Michael Taylor, and Suzanne Sechen (an FDA "primary reviewer for all rbST and other dairy drug production applications" ) were the subjects of a U.S. General Accounting Office (GAO) investigation in 1994 for their role in the U.S. Food and Drug Administration's approval of Posilac, Monsanto Corporation's formulation of recombinant bovine growth hormone (rbST or rBGH). The GAO Office found "no conflicting financial interests with respect to the drug's approval" and only "one minor deviation from now superseded FDA regulations". (Quotations are from the 1994 GAO report).
ping
ping
bump
ping
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.